News

FRIDAY, April 25, 2025 (HealthDay News) -- On Tuesday, the U.S. Department of Health and Human Services announced that the ...
A bill introduced by Republicans in the Minnesota state legislature calls mRNA vaccines "weapons of mass destruction" and if ...
Amid a multi-year surge in vaccine misinformation sparked by the Covid-19 pandemic, social media posts claimed that the ...
In the latest trading session, Moderna (MRNA) closed at $27.19, marking a -0.75% move from the previous day. This change lagged the S&P 500's 0.74% gain on the day. On the other hand, the Dow ...
Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...
In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...
MRNA contract dispute may cost Aspen R770mStock plunges 34%, biggest drop since 1998Aspen's French facility faces ...
Peter Kotlár has long promoted fringe theories about mRNA vaccines, claiming they "cause the human body to produce toxins." ...
The Senate has unanimously passed a measure that would implement labeling requirements for specific foods containing vaccines ...
Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...
Cartesian Therapeutics, Inc.’s RNAC share price has dipped by 5.62%, which has investors questioning if this is right time to ...